Keywords: BioAlliance Pharma, SpePharm, SpeBio, Loramyc, Appeal

BioAlliance Pharma files appeal to the French Supreme Court contesting decision on SpePharm and SpeBio

Article | 08 June 2011

Print This

France’s BioAlliance Pharma (Euronext Paris: BIO) has filed an appeal to the French Supreme Court contesting a preliminary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in